Cargando…
A new method to quantify tau pathologies with (11)C-PBB3 PET using reference tissue voxels extracted from brain cortical gray matter
BACKGROUND: Quantitative in vivo imaging of tau pathologies potentially improves diagnostic accuracy of neurodegenerative tauopathies and would facilitate evaluation of disease-modifying drugs targeting tau lesions in these diseases. Tau pathology can be quantified by reference tissue models without...
Autores principales: | Kimura, Yasuyuki, Endo, Hironobu, Ichise, Masanori, Shimada, Hitoshi, Seki, Chie, Ikoma, Yoko, Shinotoh, Hitoshi, Yamada, Makiko, Higuchi, Makoto, Zhang, Ming-Rong, Suhara, Tetsuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4788664/ https://www.ncbi.nlm.nih.gov/pubmed/26969002 http://dx.doi.org/10.1186/s13550-016-0182-y |
Ejemplares similares
-
In vivo binding of a tau imaging probe, [(11)C]PBB3, in patients with progressive supranuclear palsy
por: Endo, Hironobu, et al.
Publicado: (2019) -
Association between Aβ and tau accumulations and their influence on clinical features in aging and Alzheimer's disease spectrum brains: A [(11)C]PBB3-PET study
por: Shimada, Hitoshi, et al.
Publicado: (2016) -
Tau imaging detects distinctive distribution of tau pathology in ALS/PDC on the Kii Peninsula
por: Shinotoh, Hitoshi, et al.
Publicado: (2019) -
A Machine Learning–Based Approach to Discrimination of Tauopathies Using [
(18)F]PM‐PBB3 PET Images
por: Endo, Hironobu, et al.
Publicado: (2022) -
Tau-induced focal neurotoxicity and network disruption related to apathy in Alzheimer’s disease
por: Kitamura, Soichiro, et al.
Publicado: (2018)